Dr. Christopher Grubb told the FDA panel that COX-2 inhibitors need to be kept on the market despite potentially dangerous side effects because troops overseas would suffer without them.
"Consider our military in this particular drug decision," Grubb said, adding that troops use COX-2 drugs because traditional pain relievers such as aspirin have been linked to excess bleeding.
Without them, the United States wouldn't be able to have as many troops on the battlefield, he said.
"Coxhibs are essential in the global war on terrorism."
bryan at dumka dot com
The presence of those seeking the truth is infinitely to be preferred to the presence of those who think they've found it.